Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Arcona

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Epilepsy & Behavior : E&B|June 9, 2005
Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorderWon Chan Lee, Steve Arcona, Simu K Thomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Increasing Patient Involvement in Drug DevelopmentMaria M Lowe, David A Blaser, Lisa Cone, et al.
Current Medical Research and Opinion|November 11, 2003
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medicationsIbrahim S Al-Zakwani, John J Barron, Michael F Bullano, et al.
Patient Preference and Adherence|March 3, 2026
Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling SurveyKristin Richards, Anton L V Avanceña, Michael Johnsrud, et al.
The American Journal of Managed Care|June 26, 2018
Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013Bruce C Stuart, Sarah E Tom, Michelle Choi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Epilepsy & Behavior : E&B|June 9, 2005
Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorderWon Chan Lee, Steve Arcona, Simu K Thomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Increasing Patient Involvement in Drug DevelopmentMaria M Lowe, David A Blaser, Lisa Cone, et al.
Current Medical Research and Opinion|November 11, 2003
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medicationsIbrahim S Al-Zakwani, John J Barron, Michael F Bullano, et al.
Patient Preference and Adherence|March 3, 2026
Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling SurveyKristin Richards, Anton L V Avanceña, Michael Johnsrud, et al.
The American Journal of Managed Care|June 26, 2018
Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013Bruce C Stuart, Sarah E Tom, Michelle Choi, et al.
Pageof 3